Richard Chesworth Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Richard Chesworth is Chief Scientific Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Aug 27, 2021, when has been sold 33,779 shares (Common Stock) at a price of $60.12 per share, resulting in proceeds of $2,030,793. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Richard Chesworth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 27 2021
SELL
Open market or private sale
$2,030,793 $60.12 p/Share
33,779 Reduced 100.0%
0 Common Stock
Aug 27 2021
BUY
Exercise of conversion of derivative security
$675,580 $20.0 p/Share
33,779 Added 50.0%
33,779 Common Stock
Aug 17 2021
SELL
Open market or private sale
$2,754,540 $51.01 p/Share
54,000 Reduced 100.0%
0 Common Stock
Aug 17 2021
BUY
Exercise of conversion of derivative security
$1,080,000 $20.0 p/Share
54,000 Added 50.0%
54,000 Common Stock
RC

Richard Chesworth

Chief Scientific Officer
Watertown, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR